JP2016519950A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016519950A5 JP2016519950A5 JP2016516145A JP2016516145A JP2016519950A5 JP 2016519950 A5 JP2016519950 A5 JP 2016519950A5 JP 2016516145 A JP2016516145 A JP 2016516145A JP 2016516145 A JP2016516145 A JP 2016516145A JP 2016519950 A5 JP2016519950 A5 JP 2016519950A5
- Authority
- JP
- Japan
- Prior art keywords
- intein
- fusion protein
- seq
- peptide
- mxe gyra
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000017730 intein-mediated protein splicing Effects 0.000 claims 13
- 238000000034 method Methods 0.000 claims 12
- 108020001507 fusion proteins Proteins 0.000 claims 10
- 102000037865 fusion proteins Human genes 0.000 claims 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims 10
- 101800002094 Mxe GyrA intein Proteins 0.000 claims 7
- 235000001014 amino acid Nutrition 0.000 claims 3
- 235000018417 cysteine Nutrition 0.000 claims 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 3
- 230000035772 mutation Effects 0.000 claims 3
- 238000000746 purification Methods 0.000 claims 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- 108010054814 DNA Gyrase Proteins 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 108091005804 Peptidases Proteins 0.000 claims 1
- 239000004365 Protease Substances 0.000 claims 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- 238000001042 affinity chromatography Methods 0.000 claims 1
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 238000004587 chromatography analysis Methods 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 claims 1
- -1 linker amino acids Chemical class 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000007017 scission Effects 0.000 claims 1
- 150000003573 thiols Chemical class 0.000 claims 1
- 230000009261 transgenic effect Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13170009.8 | 2013-05-31 | ||
| EP13170009 | 2013-05-31 | ||
| US201361833046P | 2013-06-10 | 2013-06-10 | |
| US61/833,046 | 2013-06-10 | ||
| PCT/EP2014/061048 WO2014191455A1 (en) | 2013-05-31 | 2014-05-28 | Methods for producing peptides using engineered inteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016519950A JP2016519950A (ja) | 2016-07-11 |
| JP2016519950A5 true JP2016519950A5 (enExample) | 2017-07-13 |
Family
ID=48536725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016516145A Withdrawn JP2016519950A (ja) | 2013-05-31 | 2014-05-28 | 操作されたインテインを使用してペプチドを生産する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9670257B2 (enExample) |
| EP (1) | EP3003357A1 (enExample) |
| JP (1) | JP2016519950A (enExample) |
| CN (1) | CN105263509A (enExample) |
| WO (1) | WO2014191455A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9771412B2 (en) * | 2014-10-31 | 2017-09-26 | Wisconsin Alumni Research Foundation | Engineered intein for improved production of protein-intein fusions |
| SG10201801320UA (en) * | 2014-11-03 | 2018-04-27 | Merck Patent Gmbh | Soluble intein fusion proteins and methods for purifying biomolecules |
| US11136360B2 (en) | 2018-12-19 | 2021-10-05 | Tsinghua University | Fusion proteins comprising a Mtu ΔI-CM intein variant and methods of protein purification |
| CN114450406B (zh) * | 2019-09-09 | 2025-07-15 | 武汉友芝友生物制药股份有限公司 | 一种断裂型内含肽、使用其的重组多肽的制备方法 |
| GB202300816D0 (en) | 2023-01-19 | 2023-03-08 | Isomerase Therapeutics Ltd | Novel method |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9708918D0 (en) | 1997-05-01 | 1997-06-25 | Ppl Therapeutics Scotland Ltd | Methods |
| AU4380599A (en) | 1998-06-26 | 2000-01-17 | Ppl Therapeutics (Scotland) Limited | Methods for production of recombinant polypeptides |
| EP1117693B1 (en) | 1998-09-30 | 2006-05-17 | New England Biolabs, Inc. | Intein mediated peptide ligation |
| FI20021726A0 (fi) | 2002-09-27 | 2002-09-27 | Ctt Cancer Targeting Tech Oy | Menetelmä peptidien tuottamiseksi |
| US9249181B2 (en) | 2010-09-13 | 2016-02-02 | Amylin Pharmaceuticals, Llc | C-terminal amidation of polypeptides |
| WO2012100176A2 (en) * | 2011-01-20 | 2012-07-26 | University Of Rochester | Macrocyclic compounds with a hybrid peptidic/non-peptidic backbone and methods for their preparation |
| ES2618632T3 (es) * | 2011-09-28 | 2017-06-21 | Zera Intein Protein Solutions, S.L. | Inteínas divididas y usos de éstas |
-
2014
- 2014-05-28 WO PCT/EP2014/061048 patent/WO2014191455A1/en not_active Ceased
- 2014-05-28 JP JP2016516145A patent/JP2016519950A/ja not_active Withdrawn
- 2014-05-28 US US14/893,349 patent/US9670257B2/en not_active Expired - Fee Related
- 2014-05-28 EP EP14727800.6A patent/EP3003357A1/en not_active Withdrawn
- 2014-05-28 CN CN201480030331.8A patent/CN105263509A/zh not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP18083561A (es) | Proteínas de fusión gdf15 y usos de estas | |
| MX2017003847A (es) | Proteinas biespecificas activables por proteasas. | |
| WO2014202616A3 (en) | Rasamsonia gene and use thereof | |
| MX2017006866A (es) | Pares de unión para producción de péptidos. | |
| MX387465B (es) | Marcas genéticas de transgenes y métodos de uso. | |
| WO2013091661A3 (en) | Proteolytic resistant protein affinity tag | |
| JP2016526909A5 (enExample) | ||
| MX2021000030A (es) | Metodos y composiciones que utilizan polipeptidos variantes klotho. | |
| CL2013001124A1 (es) | Anticuerpo aislado o una proteína que comprende una porción de enlace de antígeno de un anticuerpo dirigido contra un polipéptido de cd40; composicion farmacéutica que comprende dicho anticuerpo; ácido nucleico que codifica el anticuerpo; vector de clonación; proceso de producción del anticuerpo. | |
| NZ724196A (en) | Uti fusion proteins | |
| JP2016520531A5 (enExample) | ||
| IN2012DN02981A (enExample) | ||
| MX382218B (es) | Variantes de lipasa y polinucleotidos que las codifican. | |
| MX2016011637A (es) | Metodos y composiciones para secrecion de polipeptidos heterologos. | |
| NZ769391A (en) | Serpin fusion polypeptides and methods of use thereof | |
| WO2012028523A3 (en) | Prokaryotic expression construct | |
| WO2014122161A3 (en) | Use of polypeptides having protease activity in animal feed | |
| BR112019001605A2 (pt) | processo para a preparação de proteína ou peptídeo | |
| AR103586A1 (es) | Proteínas quiméricas que mejoran la actividad de los dominios de unión a adn y factores de transcripción en plantas | |
| WO2007125371A3 (en) | Process for making oligopeptides | |
| MX391507B (es) | Eliminacion de ligandos lixiviados de purificacion de afinidad. | |
| MX370305B (es) | Proteína estructurante de hielo. | |
| AR131904A2 (es) | Secuencias de nucleótidos mutadas aisladas que codifican una proteína oleato desaturasa modificada de girasol, proteína modificada, métodos y usos | |
| MX2016006586A (es) | Identificacion de una citocina de linfocitos b novedosa. | |
| WO2018081350A8 (en) | SIGNAL POLYPEPTIDE FOR ENHANCED PROTEIN SECRETION |